EHealth Price To Free Cash Flows Ratio from 2010 to 2024

EHTH Stock  USD 8.04  0.12  1.52%   
EHealth's Price To Free Cash Flows Ratio is decreasing with very volatile movements from year to year. Price To Free Cash Flows Ratio is estimated to finish at -13.28 this year. For the period between 2010 and 2024, EHealth, Price To Free Cash Flows Ratio quarterly trend regression had mean deviation of  74.20 and range of 617. View All Fundamentals
 
Price To Free Cash Flows Ratio  
First Reported
2010-12-31
Previous Quarter
(13.98)
Current Value
(13.28)
Quarterly Volatility
147.28109075
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check EHealth financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EHealth's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.9 M, Interest Expense of 11.5 M or Selling General Administrative of 46.8 M, as well as many indicators such as Price To Sales Ratio of 0.51, Dividend Yield of 0.0116 or PTB Ratio of 0.26. EHealth financial statements analysis is a perfect complement when working with EHealth Valuation or Volatility modules.
  
Check out the analysis of EHealth Correlation against competitors.
For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.

Latest EHealth's Price To Free Cash Flows Ratio Growth Pattern

Below is the plot of the Price To Free Cash Flows Ratio of eHealth over the last few years. It is EHealth's Price To Free Cash Flows Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EHealth's overall financial position and show how it may be relating to other accounts over time.
Price To Free Cash Flows Ratio10 Years Trend
Very volatile
   Price To Free Cash Flows Ratio   
       Timeline  

EHealth Price To Free Cash Flows Ratio Regression Statistics

Arithmetic Mean26.97
Geometric Mean24.08
Coefficient Of Variation546.01
Mean Deviation74.20
Median(13.28)
Standard Deviation147.28
Sample Variance21,692
Range617
R-Value(0.09)
Mean Square Error23,152
R-Squared0.01
Significance0.74
Slope(3.11)
Total Sum of Squares303,684

EHealth Price To Free Cash Flows Ratio History

2024 -13.28
2023 -13.98
2022 -3.12
2021 -3.72
2020 -13.96
2019 -25.09
2018 -55.78

About EHealth Financial Statements

Investors use fundamental indicators, such as EHealth's Price To Free Cash Flows Ratio, to determine how well the company is positioned to perform in the future. Although EHealth's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Price To Free Cash Flows Ratio(13.98)(13.28)

Currently Active Assets on Macroaxis

When determining whether eHealth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ehealth Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ehealth Stock:
Check out the analysis of EHealth Correlation against competitors.
For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EHealth. If investors know EHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.108
Earnings Share
(2.62)
Revenue Per Share
16.016
Quarterly Revenue Growth
(0.1)
Return On Assets
(0.01)
The market value of eHealth is measured differently than its book value, which is the value of EHealth that is recorded on the company's balance sheet. Investors also form their own opinion of EHealth's value that differs from its market value or its book value, called intrinsic value, which is EHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EHealth's market value can be influenced by many factors that don't directly affect EHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if EHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.